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ABSTRACT 
 
The lateral line system is composed of a series of mechanoreceptors called 
neuromasts, which are found on the head and trunk in specific patterns. On the head, 
larger canal neuromasts (CNs) are enclosed in cranial canals and smaller superficial 
neuromasts (SNs) are embedded in the skin in lines or clusters. Among species the 
lateral line canals can be narrow, widened, branched, or reduced. Through the use of 
fluorescent stains, Scanning Electron Microscopy, and cleared and stained specimens 
the distribution and ontogenetic appearance of SNs and CNs were mapped in two 
species of Lake Malawi cichlids with divergent adult lateral line morphologies: 
Tramitichromis sp. (narrow canals) and A. stuartgranti stuartgranti (widened 
canals).This study provides: 1) the first description of cranial neuromast distributions 
in representatives of the genera Tramitichromis and A. stuartgranti , 2) evidence that 
CN patterning is the same in the 2 taxa despite differences in adult canal morphology, 
3) evidence that SN patterns (e.g., 9 groups of NM) are the same, but SN numbers 
vary between the two taxa, and 4) evidence that the timing and appearance of some 
SN groups varies between the two species. 
Chemical and pharmacological ablation of neuromasts are methods frequently 
used to inactive the lateral line system. Fluorescent staining of neuromasts is also a 
common technique used to visually assess the effects of ablation on neuormasts. The 
two techniques, however, have only been used sequentially once before to verify that 
lateral line ablation occurred and that the behavior of the fish was a reflection of this. 
  
 
The interpretation of the use of these methods and how they might 
differentially affect SNs and CNs is very ambiguous. This study provides the first 
detailed description of the ablation effects of Cobalt (II) chloride heptahydrate and 
Gentamicin on superficial and canal neuromasts using fluorescence staining (4-Di-2-
ASP). Two species of Lake Malawi cichlids, Tramitichromis sp. and A. stuartgranti 
stuartgranti, were used in this study.  Following treatment, it was determined that: 1) 
CoCl2 in Ca
++
 free water and Gentamicin had comparable effects on SNs and CNs in 
both species, 2) Treatment with CoCl2 in Ca
++ 
free water and Gentamicin resulted in 
full recovery of both superficial and canal neuromasts by Day 4 or Day 7, 3) 
Treatment with CoCl2 in tank water with Ca
++
 did not effectively ablate SNs and CNs 
on Day 0, when compared to CoCl2 in Ca
++
 free water and Gentamicin, 4) Gentamicin 
does, in fact, affect SNs, which refutes previous experiments.  The stain 4-Di-2-ASP 
proved to be a reliable and effective means of visually documenting the effects of 
Cobalt (II) chloride heptahydrate and Gentamicin on ablation and recovery of 
superficial and canal neuromasts in two cichlid species.
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PREFACE 
This thesis was written and formatted following the guidelines presented by the 
University of Rhode Island Graduate School for Manuscript Form. There are two 
chapters: Distribution and Development of Cranial Neuromasts in two Cichlids with 
Divergent Adult Lateral Line Canal Morphology (Chapter 1), and Susceptibility and 
Recovery of Canal and Superficial Neuromasts to Cobalt Chloride and Gentamicin 
Ablation in Two Lake Malawi Cichlid Fishes: A Comparative Study (Chapter 2). This 
study was conducted under approved URI IACUC protocol # AN-08-11-005.  
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INTRODUCTION 
 
The mechanosensory lateral line system of fishes is composed of a series of 
receptor organs called neuromasts, which are found on the head and trunk. Two types 
of neuromasts are found in juvenile and adults of bony fishes:  larger canal neuromasts 
enclosed in canals (canal neuromasts, CN), and smaller superficial neuromasts (SN) 
that are embedded in the skin in lines or clusters.  SNs are sensitive to water flow 
velocity, and CNs are sensitive to water flow acceleration in response to flows outside 
of the canals (Coombs et al. 2001). CNs are located in lateral line canals located in a 
conserved subset of the dermal bones of the head. They are narrow, widened, 
branched, or reduced among teleosts (Webb, 1989b). Narrow canals, which are the 
most common, are well-ossified and are perforated by pores in precise locations. In 
contrast, widened canals, which have evolved convergently in a small number of 
teleost families (Webb, 1989a) have bony canal walls, but largely unossified canal 
roofs and the canals tend to be wider in diameter. The CNs sit beneath thin bony 
bridges and large bony pores are in the canal roof, which is covered by an epithelium 
that is pierced by very small pores that connect the fluid inside the canal with the 
external environment.  
The analysis of neuromast migration and patterning and the genetic 
mechanisms underlying these processes have been studied extensively in zebrafish 
(Sapede et al., 2002; Ghysen and Dambly-Chaudiere, 2004), but the relationship of the 
distribution of neuromasts in embryos and young larvae to subsequent processes of 
neuromast maturation and canal morphogenesis has only been investigated in detail in 
 2 
 
zebrafish (Webb and Shirey, 2003), and in a few cichlid species (Webb, 1989c; Tarby 
and Webb, 2003) all of which are characterized by narrow lateral line canals. The 
diversity found in the lateral line system of fishes has been attributed to differences in 
the pattern and timing of development (Webb, 1989a), but the development of the 
lateral line system in closely related species characterized by divergent adult 
morphologies is still lacking. Thus, information is needed on: 1) the distribution of 
CNs and SNs in juveniles and adults of narrow canal and widened canal species, and 
2) the ontogeny of neuromast distribution and morphology in embryos and larvae of 
narrow and widened canal species. Two closely related cichlid species, 
Tramitichromis sp. (narrow canals) and A. stuartgranti stuartgranti (widened canals), 
were used in this study to represent these two lateral line canal morphologies.  
Chemical and pharmacological ablations of neuromasts are methods frequently 
used to assess the impact of an inactive lateral line system on behavior. These 
techniques are commonly used on model species such as zebrafish and Mexican blind 
cave fish (Van Trump et al., 2010; Buck et al., 2012). Fluorescent staining of 
neuromasts is also a common technique used to visually assess the effects of ablation 
on neuromasts. The two techniques, however have only been used sequentially once 
before to verify that lateral line ablation occurred and that behavior was a reflection of 
this (Schwalbe et al., 2012).  
Cobalt (II) chloride heptahydrate (Co
2+
) has been shown to block the 
mechanoreceptor channels of hair cells in neuromasts of fish (Baumann & Roth, 1986; 
Karlsen and Sand, 1987), rendering the neuromast unresponsive to water flows. This 
effect was tested by Karlsen and Sand (1987) on the roach (Rutilus rutilus). They 
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found the effects of cobalt were reversed (behavioral reaction to a vibrating ball) after 
2-3 weeks, through an increase in calcium (i.e., placing them in normal tank water). 
Aminoglycoside antibiotics selectively block transduction channels including 
Ca
++
 channels (Hudspeth and Kroese, 1983; Kroese et al., 1989; Pichler et al. 1996) in 
sensory hair cells. As in the inner ear, neuromast hair cells are mechanoreceptors in 
which the opening of Ca
++
 channels is essential for their function. The effects of 
aminoglycosides on lateral line function have been assessed visually and behaviorally 
(Montgomery et al., 1997; Coombs et al., 2001). The effects of gentamicin on 
superficial and canal neuromasts in the Mexican blind cavefish (Astyanax mexicanus) 
and zebrafish (Danio rerio) have been investigated, with the finding that both types of 
neuromasts are inactivated (Van Trump et. al. 2010).  
Hair cells can be visualized in vivo using fluorescent styryl dyes, like DASPEI 
(2-(4-(dimethylamino)styryl)-N-ethylpyridinium iodide) , FM1-43 ((n-
(3triethylammoniumpropyl)-4-(4-(dibutylamino)styryl) pyridinium dibromide), and 4-
Di-2-ASP. The fluorescent stain 4-Di-2-ASP enters the mechanotransduction Ca 
++ 
channels of hair cells and stains mitochondria (Magrassi et al., 1987), allowing 
visualization of functional hair cells and support cells in superficial and canal 
neuromasts.  
 Most ablation and staining research has been conducted on fish with narrow 
lateral line canals, either zebrafish (Chiu et al., 2008; Coffin et al., 2009; Harris et al., 
2003; Ou et al., 2007; Owens et al., 2007; Van Trump et al., 2010; Buck et al., 2012) 
or Mexican blind cave fish (Van Trump et al., 2010; Buck et al., 2012). The two 
 4 
 
species used in this study represent narrow (Tramitichromis) and widened 
(Aulonocara) canal morphologies.  
The interpretation of the use of these methods and how they might 
differentially affect SNs and CNs is very ambiguous. Thus, a clear description of 
which staining techniques and ablation methods work best on narrow and widened 
canal species is needed in order to verify previous lateral line ablation behavior 
experiments. 
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ABSTRACT 
 
The lateral line system is composed of a series of mechanoreceptors called 
neuromasts, which are found on the head and trunk in specific patterns. On the head, 
larger canal neuromasts (CNs) are enclosed in cranial canals and smaller superficial 
neuromasts (SNs) are embedded in the skin in lines or clusters. Among species the 
lateral line canals can be narrow, widened, branched, or reduced. Through the use of 
fluorescent stains, Scanning Electron Microscopy, and cleared and stained specimens 
the distribution and ontogenetic appearance of SNs and CNs were mapped in two 
species of Lake Malawi cichlids with divergent adult lateral line morphologies: 
Tramitichromis sp. (narrow canals) and A. stuartgranti stuartgranti (widened 
canals).This study provides: 1) the first description of cranial neuromast distributions 
in representatives of the genera Tramitichromis and A. stuartgranti , 2) evidence that 
CN patterning is the same in the 2 taxa despite differences in adult canal morphology, 
3) evidence that SN patterns (e.g., 9 groups of NM) are the same, but SN numbers 
vary between the two taxa, and 4) evidence that the timing and appearance of some 
SN groups varies between the two species. 
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INTRODUCTION 
The mechanosensory lateral line system of fishes is composed of a series of 
receptor organs called neuromasts, which are found on the head and trunk. Two types 
of neuromasts are found in juveniles and adults of bony fishes:  larger canal 
neuromasts enclosed in canals (canal neuromasts, CN), and smaller superficial 
neuromasts (SN) that are embedded in the surface of the skin in lines or clusters. 
Neuromasts detect water flows. Superficial neuromasts are sensitive to flow velocity, 
and canal neuromasts are sensitive to accelerations in response to flows outside of the 
canals (Coombs et al. 2001). Cranial lateral line canals are located in a conserved 
subset of the dermal bones of the head. They are narrow, widened, branched, or 
reduced among species (Webb, 1989b). Narrow canals, which are most common 
among fishes, are well-ossified and are perforated by pores in precise locations. In 
contrast, widened canals, which have evolved convergently in a small number of fish 
families (Webb, 1989a) have bony canal walls, but largely unossified canal roofs and 
the canals tend to be wider in diameter. The CNs sit beneath thin bony bridges and 
large bony pores are in the canal roof, which is covered by an epithelium that is 
pierced by very small pores that connect the fluid inside the canal with the external 
environment (see Fig. 1 for size comparison).  
Neuromasts in narrow canals tend to be oval in shape, with their major axis 
and an elongated sensory strip (containing the sensory hair cells) parallel to the long 
axis of the canal. Hair cells in the sensory strip are surrounded by non-sensory support 
cells that secrete the cupula and determine the overall shape of the neuromast (Webb, 
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2000a). In widened canals, neuromasts are generally much larger than those in narrow 
canals and have a prominent axis perpendicular to the canal axis, but the orientation of 
the hair cells is parallel to the canal axis. As in neuromasts in narrow canals, support 
cells surround the sensory strip so that neuromasts in widened canals often have a 
diamond shape (e.g., Jakubowski, 1967).  
The formation of the lateral line system begins during embryogenesis and has 
been described as three phases (Webb 1989b).  First, the primordium of the 
neuromasts, which is derived from cranial lateral line placodes, migrates from the 
head to the tail and establishes the distribution of neuromasts along the body (Lopez-
Schier et al. 2004). In addition to establishing the distribution of neuromasts, each 
lateral line placode gives rise to the sensory neurons to innervate each neuromast 
(Münz, 1979; Gibbs 2004). The second phase involves the maturation and growth of 
neuromasts in length and width (Tarby and Webb 2003, Webb and Shirey 2003). In 
the third phase, the lateral line canals form in four stages in which individual 
neuromasts gradually become enclosed in tubular canal segments (Tarby and Webb, 
2003; Webb and Shirey 2003) and the canals form and become integrated within the 
dermal cranial bones. 
The analysis of neuromast migration and patterning and the genetic 
mechanisms underlying these processes have been studied extensively in zebrafish 
(Sapede et al., 2002; Ghysen and Dambly-Chaudiere, 2004), but the relationship of the 
distribution of neuromasts in embryos and young larvae to subsequent processes of 
neuromast maturation and canal morphology has only been investigated in detail in 
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zebrafish (Webb and Shirey, 2003) and in a few cichlid species (Webb, 1989c; Tarby 
and Webb, 2003) all of which are characterized by narrow lateral line canals.  
The diversity found in the lateral line system of fishes has been attributed to 
differences in the pattern and timing of development (Webb, 1989a), but the 
development of the lateral line system in closely related species characterized by 
divergent adult morphologies is still lacking. This study addresses a fundamental 
question: what is the relationship between neuromast patterning and adult lateral line 
morphology? It will test the hypothesis that two related species with divergent adult 
lateral line morphologies (narrow and widened cranial lateral line canals) have the 
same complement and number of canal and superficial neuromasts. Thus, the approach 
of this project was to: 1) describe the distribution of canal and superficial neuromasts 
in juveniles and adults of two Lake Malawi cichlid species: one with narrow canals 
(Tramitichromis sp.) and one with widened canals (A. stuartgranti stuartgranti), and 
2) describe the ontogeny of neuromast distribution and morphology in embryos and 
larvae of these two species.  
 
MATERIAL AND METHODS 
Study Species 
Tramitichromis sp. and A. stuartgranti stuartgranti are mouth-brooding 
cichlids endemic to Lake Malawi (Africa), which are commercially available and 
easily reared in a lab setting. Breeding tanks in two flow- through systems were lined 
with a mixture of sand and gravel, provided with mechanical and biological filtration 
and kept at 80 ±1°F and salinity of 1±0.5 ppt with a 12L:12D hour light regime. A 
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breeding group of one male and several females were provided with PVC pipe and 
rocks to mimic their natural habitat in order to promote breeding. Animals were fed 
daily on a varied diet (protein pellets, live brine shrimp, a pea/shrimp mixture, or an 
algae/yolk/earthworm protein flake mixture).  The date on which a brood was noticed 
(e.g., expanded buccal cavity observed in female) was recorded, an indication that 
fertilization had occurred within 24 hours. Broods of yolk sac larvae (at least 4 days 
post fertilization (dpf)) were removed from the mouth of brooding females and raised 
in round-bottomed glass flasks with slow water exchange within 1 liter tanks in an 
Aquatic Habitats recirculating rack system. After yolk sac absorption, actively 
swimming larvae would swim out of the flasks, and were then fed a flake mixture of 
egg yolk, earthworm protein, and algae.  Ontogenetic series were generated from 6 
broods (all half siblings; same father) of Tramitichromis sp. and 7 broods 
(relationships unknown) of A. stuartgranti by sampling fish every 1-3 days (e.g., 1- 2 
mm SL intervals).  
 
Neuromast Staining and Imaging  
The fluorescent mitochondrial stains 4-Di-2-ASP (4-(4-(diethylamino) styryl)-
N-methylpyridinium Iodide; Sigma Aldrich) and DASPEI (2-(4-(dimethylamino) 
styryl)-N-ethylpyridinium iodide; Sigma Aldrich) were used to document the spatial 
distribution of neuromasts on the head in embryos, larvae and adults. Neuromasts in 
the two species were visualized using 4-Di-2-ASP (>15 dpf) or DASPEI (4-15 dpf, to 
avoid interference with strong fluorescence by the gills caused by 4-Di-2-ASP).  
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Live fish were immersed for 5 minutes in a 0.0024% (63 µM) solution of 4-Di-
2-ASP in tank water or for 30 minutes in a 0.01% solution of DASPEI in tank water 
and were then anaesthetized in 0.33% buffered MS-222 (Tricaine methanesulfonate; 
Sigma Aldrich) till movements ceased. Light and fluorescent images of the lateral, 
dorsal and ventral surfaces of the head of each fish were obtained at 2x magnification 
using a Nikon dissecting microscope scope (Model SMZ1500) using a Spot digital 
camera (Model 25.22 Mp Color Mosaic) and Spot software (v. 5.0; Diagnostic 
Instruments, Sterling Heights, MI). Tracings were made from fluorescent digital 
images in ventral, lateral, and dorsal views to detail the distribution of canal and 
superficial neuromasts.  
Six adult A. stuartgranti (>154 dpf; 16-26 mm SL) and five adult 
Tramitichromis sp. (>99 dpf; 15-21 mm SL) were used to determine canal and 
superficial neuromast distributions in adults (see Fig. 4).  In addition, a total of 40 
larval and juvenile A. stuartgranti (~5-154 dpf; 6-28 mm SL) and 61 larval and 
juvenile Tramitichromis sp. (~4-99dpf; 4-18 mm SL) were used to describe the 
ontogeny of neuromast distributions.  
 
Cleared and Stained Material  
Tramitichromis sp. and A. stuartgranti previously cleared and stained (for bone 
and cartilage; Potthoff, 1984) were used to identify the location of lateral line canals 
within the dermal bones of the head. Fluorescent images (generated as above) could 
then be superimposed over images of cleared and stained fish to identify the precise 
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location of canal neuromasts within the canals. Superficial neuromasts were assigned 
names based on Peters (1973) description of neuromast distributions in tilapia.   
 
Scanning Electron Microscopy 
SEM (done by J.F. Webb) was used to reveal neuromast size, shape and hair 
cell orientation. Larval and juvenile Tramitichromis sp.(11-13 mm SL, n=12) and A. 
stuartgranti (11.5 – 16 mm SL, n=24) that had been fixed in 10% formalin in 
Phosphate Buffered Saline for up to several months (including those used for 
fluorescent imaging) were dehydrated in ethanol (50%-2 hours; 70% overnight, 80%, 
95%, 100%x3, each for ~1 hour). Fish were critical-point-dried out of liquid CO2 
(Tousimis Samdri-780A) coated with gold alloy (Leica MED 020), and mounted on 
aluminum stubs with adhesive carbon discs. Specimens were viewed with a Zeiss NTS 
Supra 40VP scanning electron microscope at 3 KV at the Marine Biological 
Laboratory, Woods Hole, MA.  
 
RESULTS 
Tramitichromis sp. and A. stuartgrant , both mouth brooders, hatch at about 4-
5 mm total length (TL) at ~5 days post-fertilization (dpf). Their prominent yolk sac is 
absorbed by about 20 dpf, just before being released from the mother’s mouth (by ~21 
dpf) at which point the fish are juveniles (Fig.2).  
A small number of neuromasts are present on the skin at hatch in both species.  
Presumptive CNs as well as other SNs (which will remain on the skin) are easily 
distinguished by size at an early age (~6 dpf in Tramitichromis sp.; ~7 dpf in A. 
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stuartgranti), well before canals begin to develop. In older larvae and early juveniles, 
the presumptive CNs increase in size and SEM revealed their diamond shape. SNs are 
smaller than CNs and are either round (e.g., in the clusters on the mandible) or 
diamond -shaped with an elongate sensory strip (e.g., on the cheek area). Hair cell 
orientation in presumptive CNs is always parallel to the axis of the canal, whereas hair 
cell orientation in SNs varies among groups or series, and may be parallel or 
perpendicular to the body axis.  
 
Distribution and Morphology of Canal Neuromasts (CNs)  
The number and distribution of CNs is the same in both species.  Five 
supraorbital canal neuromasts (SO1-5) are contained in the supraorbital (SO) canal 
and are located dorsal to and medial to the orbits (Fig. 3 A and D; Fig. 4 A and D). 
One canal pore is found between the positions of adjacent canal neuromasts along the 
canal. Neuromast SO1 is located in the tubular nasal bone, while neuromasts SO2–
SO5 are located in the portion of the SO canal that runs along the frontal bone. The 
canal begins rostral to the naris with a terminal pore that is present in both species. In 
Tramitichromis sp., SO1 is medial to the olfactory organ and is not easily visualized in 
fluorescent images due to the strong staining of the olfactory epithelium (Fig. 3 B and 
E), so histological material (N. Bird, pers. comm.) was used to identify this neuromast. 
In A. stuartgranti, SO1 is positioned further towards the dorsal midline and was easily 
visualized. A common median pore connecting the left and right SO canals is found 
between the positions of SO3 and SO4. The terminal pore of the SO canal is caudal to 
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SO5 and connects where the SO and infraorbital (IO) meet (canals not indicated in 
figure; Fig.2 A and D; Fig. 3 A and D).   
The mandibular (MD) canal contains five neuromasts (MD1-5; Fig. 3 C and F; 
Fig. 4 C and F). MD1 through MD4 are enclosed in the portion of the canal in the 
dentary bone. MD5 is contained in the short canal segment in the anguloarticular bone. 
The anterior end of the canal begins with a terminal pore, followed by MD1. One pore 
is found between adjacent neuromasts along the canal.  The posterior terminal pore of 
the MD canal in the dentary bone opens into the anguloarticular bone just after MD4; 
MD5 is contained within the canal segment in the anguloarticular. The terminal pore 
of the MD canal is found at the junction between the MD canal and the preopercular 
(PO) canal (Fig. 3 C and F; Fig. 4 C and F).  
The infraorbital (IO) canal contains nine neuromasts (IO1-9) and follows the 
circumference of the orbit, beginning in the lacrimal bone and then continuing into the 
tubular infraorbital ossicles (Fig. 3 B and E; Fig. 4 B and E). This series begins below 
the naris and IO1-3 are found in the lacrimal bone; the other six IO neuromasts (IO 4-
9) are found in the tubular infraorbital ossicles. A bony pore is found at a position 
between each two neuromasts in the series. The IO canal terminates in a pore, which is 
also the terminal pore for the SO series (Fig. 3 B and E).  
The L-shaped preopercular (PO) canal, which contains six neuromasts (PO1-
6), connects rostrally with the terminal pore of the mandibular canal and continues 
dorsally, terminating caudally to the orbit (Fig. 3 B and E).  
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Distribution and Morphology of Superficial Neuromasts 
Superficial neuromasts were found in nine series in both Tramitichromis sp. 
and A. stuartgranti and were named using a scheme for Tilapia (Peters, 1973; Table 
1). Both species have the same complement of SN series, but the number of 
neuromasts in each series differs. The nine SN series can be organized into dorsal, 
lateral and ventral series (e.g., See Table 1). 
The dorsolateral (DL) series consists of 7-9 neuromasts (Table 1) in both 
species, and forms a curved line on the top of the head at a 45-degree angle to the 
body axis (Fig. 3 A and D; Fig. 4 A and D).   
The circumnasal series (ZN) is lateral or ventral to the naris and is composed 
of 8-10 neuromasts in Tramitichromis sp.and 7-10 neuromasts in A. stuartgranti (Fig. 
3 B and E; Fig. 4 B and E). 
The supranasal series (SUN) is found on the dorsal surface of the “snout”, and 
consists of 3 transverse lines of SNs (SUN1-3) in Tramitichromis sp. and 4 transverse 
lines (SUN1-4) in A. stuartgranti. The left and right portions of these lines, which are 
presumably innervated by different nerves, cannot be clearly distinguished. Adult 
Tramitichromis have a total of 10-12 SUN neuromasts (left + right), and A. 
stuartgranti have a total of 21- 28 SUN neuromasts (left + right; Fig. 3 A and D; Fig. 
4 A and D).  
The supratemporal cross series (STC) is perpendicular to the body axis in a transverse 
line caudal to the eyes on the dorsal side of the head. It is comprised of 6-10 
neuromasts in both A. stuartgranti and Tramitichromis sp.(Fig. 3 A and D; Fig. 4 A 
and D).  
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The supracleithral cross series (ScC) is an irregular transverse line of SNs just 
rostral to the dorsal fin and caudal to the STC series in both species (Fig. 3 A and D; 
Fig. 4 A and D). Like the SUN series, the neuromasts of the right and left sides cannot 
be clearly distinguished. Tramitichromis sp. has a total of 6-9 neuromasts in this series 
(left + right), while A. stuartgranti tends to have a higher number with a total of 9-12 
neuromasts.  
The frontal cross series (FC) runs vertically and is composed of 1-4 
neuromasts in Tramitichromis sp. and 5-7 neuromasts in A. stuartgranti (Fig. 3 B and 
E; Fig. 4 B and E). It extends from the caudal end of the DL series and is visible in the 
dorsal view. 
The opercular vertical series (OVS) runs dorso-ventrally and is caudal to the 
PO canal series; it extends from the level of canal neuromast PO3 dorsally to the level 
of canal neuromast PO6. There was a difference in the quantity of neuromasts in this 
series between the two species. The OVS neuromasts in Tramitichromis sp. are in a 
linear series, but it appears that neuromast proliferation caudal to the line of 
neuromasts has resulted in the formation of a small neuromast cluster at the dorsal and 
ventral ends of the series, resulting in a total of 13-20 neuromasts (Fig. 3 B and E; Fig. 
4 B and E). A. stuartgranti shows a similar pattern, but the total number of neuromasts 
in this series was 16-26. In both species, SEM reveals that the sensory strip and the 
physiological orientation of the hair cells of the OVS neuromasts is rostro-caudal, thus 
perpendicular to the line of neuromasts in this series (Fig. 3 B and E; Fig. 4 B and E).  
The cheek vertical series (CVS) runs vertically between the IO canal and PO 
canal neuromast series (Fig. 3 B and E; Fig. 4 B and E). Its ventral-most neuromast is 
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positioned just ventral to canal neuromasts PO2 and PO3 and runs in a linear series, 
dorsally to a position between canal neuromasts IO8 and PO6. In both species, the 
CVS series consists of 8-12 neuromasts (Fig. 3 B and E; Fig. 4 B and E). In contrast to 
the OVS series, the sensory strip and the physiological orientation of the hair cells of 
the CVS neuromasts is dorso-ventral, thus parallel to the line of neuromasts in this 
series.   
The superficial mandibular (SM) series consist of four spatially distinct 
clusters (SM1-4) in Tramitichromis sp. and A. stuartgranti. The clusters are positioned 
between the bony pores (which are quite large in Aulonocara; Fig. 5 ) of the 
mandibular canal. The number of SNs within each cluster increases with fish size in 
both species, with neuromast numbers reaching 14-18 neuromasts in the series (Fig. 3 
C and F; Fig. 4 C and F). In both species, these neuromasts are round and extremely 
small (10-20 µm diameter; Fig. 5 F), and the orientation of the hair cells is 
perpendicular to the axis of the MD canal. 
 
Ontogeny of Canal Neuromast Distributions  
The number of presumptive CNs increases in late stage embryos and early 
larvae and stabilizes in larvae of 7-8 mm SL (~10-11 dpf), prior to the initiation of 
canal development (Fig. 6). Tramitichromis sp. CNs tend to be smaller than those in A. 
stuartgranti, as revealed by fluorescent images (hair cell population in sensory strip) 
and SEM (entire neuromast). For example, sensory strip length of MD CN for 
Tramitichromis sp. are ~20μm and ~30μm for A. stuartgranti in juveniles (~11 mm 
SL; Fig. 5).  
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The first presumptive SO canal neuromast is visible on the epithelium in 
Tramitichromis sp. around 4 dpf (4 mm SL). By 10 dpf (8 mm SL), Tramitichromis 
sp. have a full complement of SO NMs (Fig. 6; Table 1). In contrast, the first 
presumptive SO canal neuromasts appear at 5 dpf (5 mm SL) in A. stuartgranti. By 8 
dpf (6 mm SL), all 5 SO neuromasts are present and by 18 dpf, all SO canals appear to 
be enclosed. Tramitichromis sp. acquires a full set of SO canal neuromasts in a growth 
interval from 4- 8 mm SL, while A. stuartgranti obtains a full set in a much smaller 
growth interval of 5-6 mm SL).  
The MD canal neuromasts first appears at 5 dpf (4 mm SL) in Tramitichromis 
sp., with completion of the series at about 7 dpf (8 mm SL) (Fig. 6; Table 1). 
Mandibular canals appear to be fully enclosed about one week later at 15 dpf. In A. 
stuartgranti, the first mandibular CN appears at 4 dpf (5 mm SL), just before hatch 
(Table 1). A full complement of NM in the MD series (total 5 NM) is present at 6 dpf 
(6 mm SL), and the canals appear to be completely closed by about 16 dpf. It is the 
first set of canal neuromasts to form on A. stuartgranti. 
In Tramitichromis sp., the first presumptive IO neuromast appears at 4 dpf and 
by 7 dpf, the series is complete (Fig. 6; Table 1).  In A. stuartgranti the IO series first 
appears at 5 dpf with the complete set (9 NM) of neuromasts visible by ~11 dpf (Fig. 
6; Table 1). This canal appears to be enclosed at about 40 dpf, indicated by 
pigmentation in the skin obscuring a full view of the canal neuromasts that lie beneath 
the canal. 
In Tramitichromis sp., the first presumptive PO canal neuromast appears at 4 
dpf and is complete around 7 dpf (Fig. 6; Table 1). In A. stuartgranti , the first PO 
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neuromast is visible on the epithelium at 6 dpf. By 8 dpf, all 6 canal neuromasts are 
formed and by 17 dpf, the canal appears to be fully enclosed (Fig. 6; Table 1).  
 
 
Ontogeny of Superficial Neuromast Distributions  
In contrast to the canal neuromasts whose number stabilizes rather early, the 
number of SNs continues to increase through the larval and juvenile stages, with 
variation in the rate of neuromast addition between species and among SN series 
within a species (Fig. 7). The first appearance of SNs in the different series occurs 
from 4-15 dpf in Tramitichromis sp. and 4-11 dpf in A. stuartgranti , which is either 
during or after the first appearance of the CNs (at 4-5 dpf in Tramitichromis sp., 4-6 
dpf in A. stuartgranti ; Table 1) and after the age at which the final number of CNs is 
reached (9-10 dpf; 7-8 mm SL). By 5 dpf (just after hatch), CNs are noticeably larger 
than SNs in both species (e.g., Fig. 5). 
The timing of the first appearance of SN series varies with position on the head 
(Table 1; Fig. 8). For instance, in Tramitichromis sp., neuromasts of the SUN, CVS 
and SM series, between the nares (on the dorsal surface of the “snout”), laterally on 
the cheek and ventrally on the mandible, respectively, all first appear at 4 dpf (before 
hatch). Then neuromasts of the DL and ZF series and the STC and ScC series (all 
dorsal) appear at 6-7 dpf. Finally, the OVS series on the cheek and the FC series, 
dorsal and caudal to the orbit first appear at ~8 dpf and a week later, at 15 dpf. In 
contrast, in A. stuartgranti , neuromasts of the SM series (SM1) on the mandible 
appear at 4 dpf (before hatch), but other series, the dorsal SUN, STC series, and lateral 
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CVS series appear three days later, at 7 dpf. Neuromasts of the dorsal DL and ZN and 
lateral OVS series all appear about a day later, at 8 dpf. Finally neuromasts in the 
dorsal ScC and lateral FC series, appear several days later, at 11 dpf.  Three of the 
nine SN series (STC, OVS, SM) first appear on the same day in both species. Five of 
the nine SN series (DL, ZN, SUN, ScC, CVS) start to appear earlier in Tramitichromis 
sp. than in A. stuartgranti, but the initial appearance of the last SN series to form in 
both species starts 4 days earlier in A. stuartgranti (ScC, FC) than in Tramitichromis 
sp. (FC; Table 1).   
In both species, the number of SNs in each series increases with fish size and 
the total number of SNs on the head continues to increase throughout the juvenile 
period (Fig. 7).  The rate of neuromast addition appears to vary among series. For 
instance, neuromasts of the STC series first appears at 7 dpf in both species, but 
Tramitichromis sp. and A. stuartgranti juveniles of comparable sizes, have 3-5 SN’s in 
this series (Table 1). In contrast, neuromasts of the OVS series first appears at 8 dpf in 
both species, but juvenile Tramitichromis sp. and A. stuartgranti have 13-20 and 16-
26 SNs respectively indicating that the rate of addition is likely different in the two 
species. Finally, neuromasts of the SUN series (left and right) first appears at 4 dpf in 
Tramitichromis sp. and 7 dpf in A. stuartgranti , but their juveniles have 10-12 SNs 
and 21-28 SNs respectively, indicating that the rate of addition in A. stuartgranti must 
be higher than in Tramitichromis sp.  
The overall pattern of SN proliferation appears to be consistent in 
Tramitichromis sp. and A. stuartgranti , but varies somewhat among SN series (Fig. 
8).  The first two ZN neuromasts appear immediately rostral and caudal to the naris, 
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then SNs are added further away from the naris. The STC and ScC neuromasts first 
appear laterally and proliferate medially. The first SNs of the CVS and OVS series 
appear ventrally and proliferate dorsally. The symphyseal SM neuromasts (SM1) 
appear quite early and do not proliferate, while one neuormast appears in the position 
of each of the three other SM clusters and neuromast proliferation occurs within each 
cluster.   
 
DISCUSSION 
The present study expands our knowledge of the biology of Lake Malawi 
cichlids and the morphology and development of the lateral line system in A. 
stuartgranti stuartgranti and Tramitichromis sp. Fluorescent images, cleared and 
stained specimens, and SEMs provided us with extensive information regarding canal 
morphology, neuromast ontogeny and distribution, and hair cell orientation.   
This study provides: 1) the first description of cranial neuromast distributions 
in Tramitichromis and A. stuartgranti , 2) shows that CN patterning is the same 
despite differences in adult canal morphology, 3) shows that SN patterns (e.g., 9 
groups of NM) are the same, but SN numbers vary between the two species, and 4) 
shows that the timing and appearance of some SN groups varies between species. The 
two species investigated in this study both possess lateral line characteristics that are 
indicative of teleosts more broadly (Webb, 1989b ) including: 1) four major cranial 
lateral line canals,  2) size differences between CNs and SNs, and 3) the organization 
of SNs into distinct clusters and lines.  
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Canal and superficial neuromasts in early larval zebrafish have previously been 
mapped using fluorescent markers and have been named according to both their 
location and innervation (Raible and Kruse, 2000). When we labeled CNs and SNs 
with 4-Di-2-ASP and compared them with other cichlid species with narrow canals 
(i.e., Oreochromis spp., Peters, 1973; Archocentrus nigrofasciatus, Tarby and Webb, 
2003), we found that CN distribution and number is identical. This was not surprising, 
as subsequent differences in CN maturation (resulting in differences in CN size 
between species) and the degree of ossification in the canal roof result in divergent 
lateral line morphology, not the differences in initial CN number or distribution. 
Superficial neuromasts in both species are similar in their distribution, but the 
differences were found in the number of neuromasts. Most SNs are closely associated 
with CN series and are not randomly distributed over the head (Fig. 3 and Fig. 4), as in 
other teleost fishes (reviewed in Coombs et al. 1988). In teleosts, SNs also typically 
show varying physiological orientations (due to polarization of hair cells within NMs) 
depending on what SN group they are found in (Janssen et al., 1987; Song and 
Northcutt, 1991; Coombs and Montgomery, 1994). Based on SEMs, it was determined 
that this is also the case for the SNs in Tramitichromis sp. and A. stuartgranti (Fig. 5). 
The SNs found in specific groups, lines, or clusters, are assumed to be innervated by 
the same branch of a lateral line nerve, although more work needs to be done to verify 
this in the two study species. The greatest difference in lateral line morphology 
between Tramitichromis sp. and A. stuartgranti (besides canal morphology) is not 
found in the distribution of CNs, but in the proliferation of SNs within specific series.  
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Neuromast number and distribution is important in understanding the evolutionary 
relationships among fish taxa (Nakae et al., 2011;Nelson 1969; Nakae and Sasaki 
2010). The data presented here points to differences in adult lateral line canal 
morphology (narrow vs. widened canals) that are correlated with differences in CN 
maturation (resulting in differences in CN size between species), and the degree of 
lateral line canal morphogenesis (degree of ossification of canal roof). They do not 
suggest that differences in CN number or distribution are related to the evolution of 
widened canals from narrow canals. In order to fully understand the evolution of the 
four lateral line canal morphologies (narrow, widened, branched, and reduced), 
additional specimen from a range of taxa still need to be examined.  
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Table 1.1. Timing of appearance of canal and superficial neuromasts in larvae and 
juveniles and number of neuromasts in older juveniles of Tramitichromis(TRA) and A. 
stuartgranti (AU).  Data from left side only-excluding SUN and ScC which are 
bilateral count.  
 
Neuromast Series Age when NM first appear # NM in older juveniles 
 TRA AU TRA AU 
Canal Neuromasts      
Supraorbital (SO) 4 dpf 5 dpf 5 5 
Mandibular (MD) 5 dpf 4 dpf 5 5 
Infraorbital (IO) 4 dpf 5 dpf 9 9 
Preopercular (PO) 4 dpf 6 dpf 6 6 
Superficial Neuromasts     
Dorsal      
Dorso-Lateral (DL) 6 dpf 8 dpf 7-9 7-9 
Circumnasal (ZN) 6 dpf 8 dpf 8-10 7-10 
Supranasal (SUN; multiple lines) 4 dpf 7 dpf 10-12 21-28 
Supratemporal Cross (STC) 7 dpf 7 dpf 3-5 3-5 
Supracleithrum Cross (ScC) 7 dpf 11 dpf 6-9 9-12 
Lateral      
Frontal Cross (FC) 15 dpf 11 dpf 1-4 5-7 
Opercular Vertical Series (OVS) 8 dpf 8 dpf 13-20 16-26 
Cheek Vertical Series (CVS) 4 dpf 7 dpf 8-12 8-12 
Ventral     
Superficial Mandibular (SM) 4 dpf 4 dpf 9-14 16-18 
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Fig.1.1 .Three-dimensional reconstructions of the mandible (ventral view) from CT 
scans (16 µm slice thickness) of A) Tramitichromis sp. (narrow canals) and B) A. 
stuartgranti stuartgranti (widened canals). Note significantly larger canal pores in 
Aulonocara. 
A B 
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Fig.1.2 .Growth of Tramitichromis sp. (black diamonds; n=61) and A. stuartgranti 
(white diamonds; n=41) used in this study (ontogeny). Arrow indicates age at which 
juveniles typically leave the mother’s mouth.  
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Fig. 1.3 . Canal (CN) and superficial (SN) neuromast distributions in dorsal, lateral and 
ventral fluorescent images. Fluorescent images of Tramitichromis sp. (A-C; narrow 
canals; 18 mm SL) and A. stuartgranti (D-F; widened canals, 21 mm SL). Sensory strip 
(hair cells) of CNs and SNs give a positive fluorescent signal. Note that CNs in A. 
stuartgranti are larger than those in Tramitichromis sp.  
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Fig. 1.4 . Canal (CN) and superficial (SN) neuromast names and distributions in dorsal, 
lateral and ventral views in Tramitichromis sp. (A-C) and A. stuartgranti (D-F). NM 
distributions are based on fluorescent images of 5 adult individuals of Tramitichromis 
sp.(narrow canals; 87-158 dpf;15-20 mm SL) and 6 adult individuals of A. stuartgranti 
stuartgranti (widened canals; 99-154 dpf; 16-26 mm SL). CNs are represented by large red 
dots/ovals (CNs in A. stuartgranti are larger than those in Tramitichromis) and SNs are 
represented by the smaller blue dots (drawn larger than actual size). Neuromast naming is 
based on Peters (1973, Zeit. Morph Tiere). See Table 1 for naming abbreviations.  
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Fig.1.5 . SEM of canals, pores, and neuromasts in juvenile Tramitichromis sp. (A) and A. stuartgranti (B-H). A) TRA (10 mm SL, 
lateral and ventral views) and MD neuromast. B) AU (~11.5 mm SL, lateral and ventral views) and MD neuromast. C) AU PO 
neuromast in canal groove (11 mm SL). D) AU IO3 and IO4 CNs, and enlargement of representative IO4 CN. E-H) Superficial 
neuromasts in AU (see table 1 for abbreviations). Double headed arrows = hair cell orientation. Rostral is to left in all images. Scale 
bars: A, A’, B, B’, C = 200µm, D = 50 µm, all individual neuromast images = 10µm. 
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Fig. 1.6 . Ontogenetic increases in total canal neuromasts (CN, black circles) and 
superficial neuromasts(SN, white circles) in larvae and juveniles of Tramitichromis 
sp. (A, n=61) and A. stuartgranti (B, n=33). Note the stabilization of CN number and 
the continual increase of SN in both species.  
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Fig.1.7 . Distribution of increasing number of superficial and large presumptive canal neuromasts in larvae and early juveniles (4-15 
dpf, 4-7 mm SL) of A) Tramitichromis sp. (narrow canals) and B) A. stuartgranti (widened).  
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Fig. 1.8 . Ontogenetic increases in dorsal, ventral, and lateral superficial groups of NM (See Table 1 for identity of SN 
groups) for A)Tramitichromis sp. and B) A. stuartgranti. 
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C F 
Fig.1.9 . Canal and superficial neuromasts in A-C) Tramitichromis sp. (10 mm SL, 12 
dpf) and D-F)A. stuartgranti (15 mmSL, 40 dpf). Dashed boxes in A and D represent the 
magnified B and E images. Note the size differences between superficial (smaller yellow 
dots) and canal (larger yellow dots) neuromasts( B and E).  Images C and F represent 
“scalloping” of the canals walls above and around the canal neuromasts (large yellow 
dots) before they meet and fuse together to form canal segments. The dashed white line 
indicates the outline of the “scallops”.  
 
 34 
 
Manuscript-2 
Prepared for Submission to Hearing Research 
 
Susceptibility and Recovery of Canal and Superficial Neuromasts to Cobalt 
Chloride and Gentamicin Ablation in Two Lake Malawi Cichlid Fishes: A 
Comparative Study 
 
Emily Becker, Jacqueline Webb 
Biological Sciences, University of Rhode Island, Kingston, RI, USA 
 
Corresponding Author: Jacqueline F. Webb, Ph.D. 
        Department of Biological Sciences 
Center for Biotechnology and Life Sciences 
University of Rhode Island 
Kingston, RI  02881  USA 
Phone: +1-401-874-2609 
Email address: jacqueline_webb@mail.uri.edu 
 
 
 
 
 
 
 
 35 
 
ABSTRACT 
Chemical and pharmacological ablation of neuromasts are methods frequently 
used to assess the impact of an inactive lateral line system on behavior. Fluorescent 
staining of neuromasts is also a common technique used to visually assess the effects of 
ablation on neuormasts. However, the two techniques have only been used in the same 
study once before to verify that lateral line ablation occurred and that behavior was a 
reflection of this. The effectiveness of these methods among treatments and how they 
affect superficial and canal neuromasts is uncertain. The current study provides the first 
detailed description of the effects of Cobalt (II) chloride heptahydrate as well as 
Gentamicin on superficial and canal neuromasts in two closely related cichlid species, 
Tramitichromis sp. and A. stuartgranti, using fluorescence staining (4-Di-2-ASP), as a 
method that can be used to verify the results of lateral line behavioral studies. Following 
treatment, it was determined that: 1) CoCl2 in Ca
++ -
free water and Gentamicin had 
comparable effects on SNs and CNs in both species, 2) Treatment with CoCl2 in Ca
++
-
free water and Gentamicin resulted in full recovery of  both superficial and canal 
neuromasts by Day 4 or 7,  3) Treatment with CoCl2 in tank water with Ca
++
 had no 
effect on SNs and CNs  fluorescence on Day 0, when compared to CoCl2 in Ca
++
-free 
water and Gentamicin,  and 4) Gentamicin does, in fact, ablate SNs, which refutes 
published reports.  
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INTRODUCTION 
The lateral line system of fishes is composed of a series of mechanoreceptors 
called neuromasts, which are found on the trunk and head in specific patterns (reviewed 
by Coombs et al. 1988). The two types of neuromasts are superficial and canal 
neuromasts. Superficial neuromasts are located on the surface of the skin and are 
sensitive to water velocity, while canal neuromasts are in fluid-filled canals and detect 
water flow accelerations (Coombs et al. 2001). Neuromasts are made up of hair cells, 
each of which has one long kinocilium and many shorter stereocilia on its apical surface. 
Within a neuromast the hair cells are located above and in between non-sensory support 
cells, which are then surrounded by mantle cells.  The ciliary bundles of the hair cells are 
physiologically polarized based on the position of the stereocilium relative to the 
kinocilia (Kasumyan, 2003). Each bundle projects into a single gelatinous cupula. The 
neuromasts of the lateral line system detect hydrodynamic flows arising from biotic and 
abiotic sources, and mediate several behaviors such as rheotaxis (Dijkgraaf, 1963; Kanter 
and Coombs, 2002) and prey detection (Hoekstra and Janssen, 1985; Montgomery and 
Coombs, 1998; Blaxter and Fuiman, 1989; Coombs et al., 2001).  
Canal neuromasts are contained within cranial lateral line canals located in a 
conserved subset of dermal bones in the head. Among bony fishes, these canals may be 
narrow, widened, branched, or reduced (Webb, 1989b). Narrow canals, which are most 
common among fishes, are well-ossified and are perforated by pores in precise locations. 
In contrast, widened canals, which have evolved convergently in a small number of fish 
families (Webb, 1989a) have bony canal walls, but largely unossified canal roofs and the 
canals tend to be wider in diameter. The canal neuromasts are located beneath thin bony 
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bridges and large bony pores are in the canal roof, which is covered by an epithelium that 
is pierced by very small pores that connect the fluid inside the canal with the external 
environment.  
Chemical and pharmacological ablation of neuromasts are methods frequently 
used to assess the impact of an inactive lateral line system on behavior. These techniques 
are commonly used on model species such as zebrafish and Mexican blind cave fish (Van 
Trump et al., 2010; Buck et al., 2012). Fluorescent staining of neuromasts is also a 
common technique used to visually assess the effects of ablation on neuormast. The two 
techniques, however have only been used sequentially once before to verify that lateral 
line ablation occurred and that behavior was a reflection of this (Schwalbe et al., 2012).  
Cobalt (II) chloride heptahydrate (Co
2+
) has been shown to block the 
mechanoreceptor channels of hair cells in neuromasts of fish (Baumann & Roth, 1986; 
Karlsen and Sand, 1987) rendering the fish unresponsive to water flows. Using the roach,  
Karlsen and Sand (1987) found the effects of cobalt in low Ca
++
  were reversed 
(evaluated using a behavioral reaction to a vibrating sphere) after 2-3 weeks, by placing 
them in normal tank water with an increased concentration of Ca
++
 . 
Aminoglycoside antibiotics selectively block hair cell transduction channels 
including Ca
++
 channels (Hudspeth and Kroese, 1983; Kroese et al., 1989; Pichler et al. 
1996). As in the inner ear, neuromast hair cells are mechanoreceptors for whose function 
the opening of Ca
++
 channels is essential. The effects of aminoglycosides on lateral line 
function have been assessed visually and behaviorally (Montgomery et al., 1997; Coombs 
et al., 2001). The effects of gentamicin on superficial and canal neuromasts in the 
Mexican blind cavefish (Astyanax mexicanus) and zebrafish (Danio rerio) has been 
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investigated, finding that both types of neuromasts are inactivated (Van Trump et. al. 
2010).  
Hair cells can be visualized in vivo using fluorescent styryl dyes, like DASPEI (2-
(4-(dimethylamino)styryl)-N-ethylpyridinium iodide) , FM1-43 ((n-
(3triethylammoniumpropyl)-4-(4-(dibutylamino)styryl) pyridinium dibromide), and 4-Di-
2-ASP. The stain FM1-43 labels hair cells (but not support cells) by entering the 
mechanotransduction channels of stereocilia. When the mechanotransduction channels 
are unable to open or are blocked, this dye fails to travel into the hair cells and they are 
not stained (Meyers et al., 2003). The stain DASPEI labels mitochondria in live cells 
(Rafael, 1980) and thus preferentially labels the mitochondria-rich hair cells of 
neuromasts and the nasal sensory epithelium. DASPEI is thought to be taken up through 
the hair cell mechanotransduction channels, but if this channel is blocked, the 
mitochondria cannot be stained. DASPEI has been reported to label not only hair cells in 
superficial and canal neuromasts, but also support cells in zebrafish larvae (Harris et al., 
2003). The stain 4-Di-2-ASP works similarly to DASPEI by entering the hair cell 
mechanotransduction channels and staining mitochondria (Magrassi et al., 1987) in hair 
cells and support cells of superficial and canal neuromasts.  
This study is the first to provide a side- by- side comparison of lateral line 
ablation methods using cobalt (II) chloride heptahydrate and gentamicin in order to 
directly compare their immediate effects as well as the timing of recovery. There is 
ambiguity among ablation treatments and how they differentially affect superficial and 
canal neuromasts.  Most ablation studies have been conducted on fish with narrow lateral 
line canals (zebrafish, Chiu et al., 2008; Coffin et al., 2009; Harris et al., 2003; Ou et al., 
 39 
 
2007; Owens et al., 2007; Van Trump et al., 2010; Buck et al., 2012; Mexican blind cave 
fish, Van Trump et al., 2010; Buck et al., 2012). The two species used in this study 
represent narrow (Tramitichromis) and widened (A. stuartgranti) canal morphologies, 
two of the four canal morphologies among teleosts. Narrow canal neuromasts tend to be 
smaller in size (with fewer hair cells) compared to widened canal neuromasts, and there 
is a possibility that differences in neuromast size may result in different susceptibility to 
one or both ablation methods. This study aimed to provide visual verification of 
neuromast function that can be used to interpret feeding behavior studies in which the 
lateral line system is ablated (Schwalbe et. al, 2012).  
 
MATERIALS AND METHODS 
Tramitichromis sp. and A. stuartgranti, mouth-brooding cichlids endemic to Lake 
Malawi (Africa), are commercially available and easily reared in a laboratory setting. 
Breeding tanks in two flow-through systems were lined with a mixture of sand and 
gravel, provided with mechanical and biological filtration, and kept at 80 ±1°F and 
salinity of 1±0.5 ppt with a 12:12 hour light: dark cycle. A breeding group of one male 
and several females were provided with PVC pipe, and rocks to mimic their natural 
habitat in order to promote breeding. Animals were fed daily on a varied diet (protein 
pellets, live brine shrimp, a pea/shrimp mixture, or an algae/yolk/earthworm protein flake 
mixture).  The date on which a brood was noticed (e.g., expanded buccal cavity observed 
in female) was recorded, an indication that fertilization had occurred within 24 hours. 
Broods of yolk sac larvae (between 4 and 8 dpf) were removed from the mouth of 
brooding females and raised in small, round-bottomed glass flasks with slow water 
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exchange within small tanks in an Aquatic Habitats recirculating rack system. After yolk- 
sac absorption, actively swimming larvae swam out of the flasks, or were removed from 
the flask, and were then fed a flake mixture of egg yolk, earthworm protein, and algae. 
 Comparison of Vital Fluorescent Stains  
In order to determine the most effective vital fluorescent stain for this study, a 
total of nine A. stuartgranti (12-16 mm SL) were vitally stained using one of three dyes 
as follows: 1) live fish were immersed in a 0.01%  DASPEI solution (Sigma Aldrich) in 
tank water (Rubel lab, http://depts.washington.edu/rubelab) for 30 minutes, or 2) live fish 
were immersed in a 63 µM 4-Di-2-ASP (Sigma Aldrich) solution in tank water (based on 
a dose response experiment using A. stuartgranti ; doses tested were:15.8µM, 31.5µM, 
47.3µM, and 63 µM [Nakae et al., 2011]; Fig. 1) for 5 minutes, or 3) live fish were 
immersed in a 3µM FM1-43 (Sigma Aldrich) solution in tank water for 45 seconds and 
rinsed with DI water (Santos, 2006).  
After treatment with one of the three stains, each fish was anesthetized with MS-
222 and immobilized in a petri dish for viewing. In a darkened room, a Nikon microscope 
(Model SMZ1500) was used to capture both light and fluorescent images on the head 
using a Spot digital camera (Model 25.22 Mp Color Mosaic) and Spot software (v. 5.0; 
Diagnostic Instruments, Sterling Heights, MI). Dark pigmentation prevented visualization 
of the canals in dorsal and lateral views. However, pigmentation over the mandibular 
canal was minimal, so all images were captured in a ventral orientation, which allowed 
for a side-by-side comparison of fluorescent staining of canal neuromasts and superficial 
neuromasts (MD 1 -5; SM1-4) in all fish. All three stains produced comparable results. 
 41 
 
After weighing cost and exposure time needed, it was decided that 4-Di-2-ASP would be 
used for all subsequent experiments (Fig. 2).  
 
Experiment # 1: Cobalt Chloride Ablation 
The effect of cobalt chloride on canal (CNs) and superficial (SNs) neuromasts 
was assessed by comparing fish treated with CoCl2 and control fish of Tramitichromis sp. 
in normal tank water or in Ca
++
 - free water. The Ca
++
 content of the Ca
++
 - free water 
was < 20 mg/L, the lowest recordable level measured with a Hach Test Kit (Hach, Model 
HA-4P, Loveland, CO). This water , made up of chemicals that do not contain Ca
++ 
(MgSO4, NaHCO3, NaCl, KCl, and KI in DI water) is described as Ca
++
 - free water here, 
to distinguish it from “tank water with Ca++”, which had 30 times the Ca++ content (660 
mg/L). During preliminary trials (Fall 2011), the effects of a 0.05 mM and a 0.1 mM 
cobalt chloride solution were tested on A. stuartgranti with and without calcium in the 
water. The results indicated that immersion in a 0.1 mM solution resulted in strong 
ablation (elimination of hair cell fluorescence). 
 In order to determine the immediate effects of treatment and the timing of 
recovery from treatment, groups of 12 Tramitichromis sp. (12-16 mm SL) were subjected 
to one of two treatments or their appropriate control for three hours: 1) 0.1 mM Cobalt 
(II) Chloride in low calcium water solution (Kocher Lab protocol: MgSO4 (7.9 g), 
NaHCO3(15.7 g), NaCl (78.0 g), KCl (17.7 g), and KI (0.57 g) in 100 liters of DI water; 
calcium hardness=20 mg/L) or low calcium water (control; Kocher Lab protocol: MgSO4 
(7.9 g), NaHCO3(15.7 g), NaCl (78.0 g), KCl (17.7 g), and KI (0.57 g) in 100 liters of DI 
water; calcium hardness< 20 mg/L), or 2) 0.1 mM Cobalt (II) Chloride solution in normal 
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tank water (with Ca
2+
; calcium hardness=660 mg/L) or tank water control (with Ca
2+
; 
calcium hardness=660 mg/L). After treatment, the four groups of fish were housed in 
separate recovery tanks with normal tank water similar to what they had been reared in 
(Calcium Hardness=660 mg/L). On each of four days (0, 2, 4, and 7 days post treatment), 
three fish were sequentially stained with 63 µM 4-Di-2-ASP in tank water for 5 minutes. 
Each fish was then transferred to a solution of 0.04% MS-222 for anesthetization and 
immobilization with pins in a Sylgard-lined Petri dish for imaging (see Fig. 3).  
This experiment was then repeated with A. stuartgranti (12-16 mm SL). Due to 
small brood sizes, some of the control A. stuartgranti were from a preliminary trial of the 
experiment carried out in summer 2012 were used here, but all A. stuartgranti exposed to 
CoCl2 were from the experiment described above.  
 
Experiment #2 : Gentamicin Ablation 
 The effect of gentamicin on both canal and superficial neuromasts was assessed in 
the two species. The procedure from Van Trump et al. (2010) was used as a guide for 
gentamicin concentration and exposure time. The effects of 0.01% (as used by Van 
Trump et al., 2010), 0.02%, 0.03%, and 0.04% gentamicin in tank water were tested on A. 
stuartgranti (See Fig. 4). A 0.04% solution of gentamicin was determined to have the 
strongest ablation results. The effect of time of exposure to gentamicin was tested using a 
0.04% gentamicin solution to confirm that 24-hour exposure (as used by Van Trump et 
al., 2010) was sufficient to achieve complete neuromast ablation, as defined here by 
reduction in neuromast fluorescence in Tramitichromis sp. and A. stuartgranti (see Fig. 
5). 
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In order to determine the immediate effects of gentamicin treatment and the 
timing of recovery, as reflected by the return of fluorescence, groups of 12 
Tramitichromis sp. (12-16 mm SL) were treated with 0.04% gentamicin sulfate solution 
in tank water for 24 hours, or placed in tank water (control) for 24 hours. The two groups 
of fish were housed in separate tanks with normal tank water similar to their rearing 
water. Then on each of four days (0, 2, 4, and 7 days post-treatment), three treatment and 
three control fish were stained with a  63 µM  4-Di-2-ASP in tank water solution for 5 
minutes. Fish were then transferred to a solution of MS-222 for anesthetization and 
immobilized with pins in a Sylgard-lined Petri dish for imaging (see Fig. 6).  This 
experiment was then repeated with A. stuartgranti (12-16 mm SL).  
 
Fluorescent Imaging and Scoring  
Both light and fluorescent images of the mandibular canal neuromasts (MD 1-5) 
and mandibular superficial neuromasts (SM series, see Chapter 1) were captured using a 
Nikon dissecting microscope (Model SMZ1500) equipped with a Spot digital camera 
(Model 25.22 Mp Color Mosaic) and Spot software (v. 5.0; Diagnostic Instruments, 
Sterling Heights, MI). Each fluorescent image was taken at the same magnification (2x) 
and an exposure of 2048 msec to facilitate comparisons among individuals, among 
treatments, and between species. Fluorescent images were then used to assess the 
fluorescence of superficial and canal neuromasts on the mandible in all fish using all 
three ablation methods on Day 0, 2, 4, and 7 days post-treatment. A scoring system 
similar to that used by Van Trump et al. (2010) in their analysis of blind cavefish and 
zebrafish was used, but different methods were necessary to analyze fluorescence in 
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canal and superficial neuromasts. The ten mandibular neuromasts (MD 1-5; left and 
right) were scored as 0, 1, or 2 (based on where each CN is located; see Chapter 1), 
where 0 = no hair cell fluorescence, 1 = partial hair cell fluorescence (< 80%, judged 
visually against the control in a dark room similar to the conditions under which the 
images were captured), and 2 = full (normal) hair cell fluorescence (Fig. 7). The scores of 
the ten neuromasts in each fish, with three fish per treatment or per control (for a total of 
30 canal neuromasts) were found to be normally distributed using the Shapiro-Wilk test 
for normality. Using a one way-ANOVA, no significant variation was found among the 3 
fish on each day in each treatment. Therefore, the mean fluorescence score was 
calculated for all three fish (30 canal neuromasts) on each day for each treatment (Prism 
v. 6.0 for Windows, GraphPad Software, La Jolla, CA USA, www.graphpad.com).  
In contrast to CNs, the mandibular SNs occur in several lines or clusters (See 
Chapter 1), vary in number among individuals and with fish size, and are not always 
found in the exact same locations, so the absence of fluorescence could not be recorded. 
Thus, we scored SNs as either 1or 2 (as defined above), but could not score neuromasts 
as 0 (absence of fluorescence). The scores of all superficial neuromasts for each of the 
three fish in all three treatments and their controls were found to be normally distributed 
using the Shapiro-Wilk test for normality. Using a one way-ANOVA, no significant 
variation was found among the 3 fish on each day in each treatment. Therefore, the mean 
fluorescence score was calculated for all of the superficial neuromasts in all three fish on 
each day for each treatment (Prism v. 6.0 for Windows, GraphPad Software, La Jolla, CA 
USA, www.graphpad.com).  
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The experimental design permitted a test of the immediate effect of cobalt 
chloride and gentamicin on SNs and CNs at Day 0, and with reference to the course of 
recovery (Day 0, 2, 4, and 7).  On Day 0 and over the 7 day recovery period, the mean 
fluorescence score between the three treatments and between the three treatments and 
their controls, were analyzed using a two-way ANOVA followed by Tukey’s multiple 
comparisons test (two independent variables: Treatment and Day; one dependent 
variable: Fluorescence Score; Prism v. 6.0 for Windows, GraphPad Software, La Jolla, 
CA USA,www.graphpad.com). 
 Figures were prepared using GraphPad Prism 6 and Adobe Illustrator CS5. 
Photographic images were cropped and arranged into plates using Adobe Photoshop CS5. 
 
RESULTS 
 Both mandibular canal neuromasts (CNs) and the much smaller mandibular 
superficial neuromasts (SNs) were strongly labeled with 4-Di-2-ASP and were visible in 
the canal series and on the epithelium overlying the canal in all control fish (Fig. 11, 12, 
13, 14). All three treatments (CoCl2 in Ca
++
 - free water, CoCl2 in tank water with Ca
++
, 
and gentamicin in tank water) resulted in reduced CN and SN fluorescence (weaker 
staining of hair cells and the absence of staining in a subset of hair cells within a 
neuromast) on one or more days (Fig. 8, 11, 12, 13, 14). Both CNs and SNs in fish treated 
with CoCl2 in Ca
++
 - free water and with gentamicin demonstrated reduced fluorescence 
on Day 0 (Fig. 11, 12, 13, 14) with an increase in fluorescence over the 7 day recovery 
period (Fig. 9, 10; Tables 1-4).  In contrast, fish treated with CoCl2 in tank water with 
Ca
++
 had variable fluorescence scores on Day 0 that were not different from their controls 
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(Fig. 9; Fig.10), with the exception of the SNs in A. stuartgranti (Fig. 10E), which 
showed reduced scores on Day 0 and a clear increase in fluorescence score over 7 days.  
 
Comparison of Treatments on Day 0  
All three treatments produced reduced neuromast fluorescence scores on Day 0 
when compared to their controls (Fig. 8; Tables 5-8). However, CoCl2 in Ca
++
 - free 
water and Gentamicin were significantly more effective (i.e. with lower fluorescence 
scores) than CoCl2 in tank water with Ca
++
 on Day 0 (Tables5-8).  
In Tramitichromis, CoCl2 in Ca
++
 - free water had a significantly greater effect, as 
indicated by lower fluorescence, on SNs and CNs than CoCl2 in tank water with Ca
++
 on 
Day 0. In Tramitichromis, CoCl2 in Ca
++
 - free water and gentamicin had similar effects 
on CN and SN fluorescence scores on Day 0, but CN and SN in gentamicin treated fish 
had significantly lower fluorescence scores on Day 0 than those treated with CoCl2 in 
tank water with Ca
++
 (see Table 5 for SN statistics; see Table 6 for CN statistics).  
In A. stuartgranti , fish treated with CoCl2 in Ca
++
 - free water had significantly 
lower fluorescence scores for CNs than those treated with CoCl2 in tank water with Ca
++ 
on Day 0. However, there was no significant difference in fluorescence scores for SNs in 
A. stuartgranti . CoCl2 in Ca
++
 - free water and gentamicin had similar effects on SN and 
CN fluorescence scores on Day 0. Gentamicin treated A. stuartgranti had significantly 
lower fluorescence scores for CNs than those treated with CoCl2 in tank water with Ca
++
 
on Day 0, but there was no reduction in fluorescence scores for SN on Day 0 (see Table 7 
for SN statistics; see Table 8 for CN statistics).  
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High- magnification images of CN’s in fish treated with cobalt chloride and 
gentamicin on Day 0 typically revealed four types of labeling: 1) hair cells labeled around 
the edge of the neuromast only, 2) hair cells labeled at the center of the neuromasts only, 
3) hair cells labeled around the edge and at the center of the neuromast, or 4) no hair cells 
labeled (Fig. 15).  
 
Recovery from Cobalt Chloride Ablation 
Tramitichromis sp. treated with CoCl2 in Ca
++
 - free water, CNs exhibited 
significantly lower fluorescence scores than did control fish on Days 0 and 2, but on Days 
4 and 7, fluorescence had increased so that there was no significant difference in 
fluorescence score between CNs in treated and control fish, which indicated recovery 
(Fig. 9A; Fig. 11; see Table 5 for statistics). Tramitichromis SNs also exhibited 
significantly lower fluorescence scores than those in control fish on Days 0 and 2. As 
with the CNs, fluorescence returned on Day 4 so that there was no significant difference 
in fluorescence score between SNs in treated and control fish. However, in contrast to the 
CNs, the SNs in treatment and control fish demonstrated a difference in fluorescence 
score on Day 7 (Fig.10A; see Table 6 for statistics).  
In A. stuartgranti treated with CoCl2 in Ca
++ 
- free water, the CNs exhibited 
significantly lower fluorescence scores than did control fish on Days 0, 2, and 4, but on 
Day 7 fluorescence increased so that there was no significant difference between 
treatment and control fish (Fig. 9 D; Fig. 12; see Table 7 for statistics). The SNs 
exhibited the same statistically significant results (Fig. 10 D; see Table 8 for statistics).  
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Tramitichromis sp. and A. stuartgranti treated with CoCl2 in tank water with 
Ca
++
did not show a decrease in neuromast fluorescence, and so these results were thus 
distinct from that obtained with fish treated with CoCl2in Ca
++
 - free water. 
 In Tramitichromis sp., CN fluorescence scores were not significantly different in 
treated fish and control fish on Days 0, 2, and 4, but, on Day 7 scores were significantly 
lower in treatment fish when compared to control fish (Fig. 9 B; Fig.11; see Table 5 for 
statistics). The SNs did not exhibit significantly lower fluorescence scores than control 
fish on Days 0, 2, and 7. However, on Day 4 there was an unexplainable difference in 
fluorescence scores in treated and control fish (Fig. 10B; see Table 6 for statistics). 
In A. stuartgranti treated with CoCl2 in tank water with Ca
++
, the CNs had the 
same fluorescence scores as those in control fish on Day 0, indicating ineffective 
ablation. However, there was a significant difference in fluorescence scores between 
treatment and control fish on Days 2 and 4 , which could not be explained (Fig. 9 E; Fig. 
12; see Table 7 for statistics). There was no difference in fluorescence scores between 
CNs in treated and control fish on Day 7, which suggests recovery. The SNs exhibited 
significantly lower fluorescence scores than those in control fish on Day 0, 2, 4, and Day 
7 (Fig. 10E; see Table 8 for statistics). Nevertheless, a trend of increasing fluorescence 
scores in treated fish was noted from Day 0 through Day 7 (Fig. 10E), suggesting that 
recovery might be occurring.  
 
Recovery from Gentamicin Ablation 
In both Tramitichromis sp. and A. stuartgranti , the CNs and SNs treated with 
gentamicin showed the same results. In Tramitichromis sp., the CNs exhibited 
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significantly lower fluorescence scores than did control fish on Days 0 and 2, but on Days 
4 and 7 there was no significant difference in fluorescence scores between treated and 
control fish (Fig. 9C; Fig. 13; see Table 5 for statistics). The SNs in Tramitichromis sp. 
exhibited the same statistically significant results as CNs (Fig.10C; see Table 6 for 
statistics). Similarly, in A. stuartgranti , the CNs had significantly lower fluorescence 
scores than those in control fish on Days 0 and 2, but on Days 4 and 7 there was no 
significant difference between treated and control fish (Fig. 9F; Fig. 14; see Table 7 for 
statistics), indicating recovery. The SNs in A. stuartgranti exhibited the same statistically 
significant results as CNs (Fig. 10 F; see Table 8 for statistics).    
 
DISCUSSION  
 
 Over the past few decades, there has been an ongoing debate over the use of 
chemical and pharmacological methods for lateral line ablation and their effects on lateral 
line-mediated behavior (Karlsen and Sand, 1987; Song et al., 1995; Baker and 
Montgomery, 1999; Janssen, 2000; Harris et al., 2003; Liao, 2006; Van Trump et al., 
2010). Most investigators have used only a change in behavior as an indicator of 
successful neuromast inactivation after treatment with cobalt or aminoglycoside 
antibiotics (Karlsen and Sand, 1987; Baker and Montgomery, 1999; Janssen, 2000; Liao, 
2006). Other investigators have used only visual verification of neuromast inactivation 
using fluorescent stains, but different methods have not been compared side-by-side 
(SEM, Song et al., 1995; DASPEI, Harris et al., 2003; DASPEI and FM1-43, Owens et 
al. ,2009;  DASPEI and 4-Di-2-ASP, Van Trump et al., 2010; Aminoglycosides, Buck et 
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al. , 2012). Only one investigator has used both behavioral and visual verification of 
neuromast ablation (CoCl2, Schwalbe et al., 2012).  
The current study has clarified the effects of two ablation methods, one chemical 
(CoCl2) and the other pharmacological gentamicin), using fluorescent staining as an 
indicator of neuromast (hair cell) survival post treatment (Harris et al., 2003).  It is clear 
from the results presented here that it is possible to ablate the hair cells of both canal and 
superficial neuromasts with either cobalt chloride or gentamicin. This study is also the 
first to visually compare the effects of cobalt and gentamicin immediately after treatment 
and over a 7-day recovery period. More specifically, the current study has shown that: 1) 
CoCl2 in Ca
++
 - free water and Gentamicin had comparable effects on SNs and CNs in 
both species, indicated by similarly low fluorescence scores on Day 0 (first visual 
comparison of cobalt and gentamicin side by side), 2) Treatment with CoCl2 in Ca
++
 - 
free water and Gentamicin resulted in full recovery of  both superficial and canal 
neuromasts by Day 4 or Day 7, as indicated by fluorescence scores that were similar to 
controls,  3) treatment with CoCl2 in tank water  with Ca
++ 
did not result in effective 
ablation of SNs and CNs, as indicated by significantly higher fluorescence scores on Day 
0, when compared to CoCl2 in Ca
++
 - free water and Gentamicin, 4) SNs and CNs treated 
with CoCl2 in tank water with Ca
++
  did not show a clear recovery over the 7 day 
recovery period (i.e. variation in fluorescence scores over the 7 days), and 5) Gentamicin 
does, in fact, ablate SNs, as revealed by low fluorescence scores after treatment on Day 0. 
These results help to clarify the conflicting results of previous studies.  
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Cobalt Chloride Ablation 
Cobalt (II) chloride heptahydrate ablation has been used to ablate the lateral line 
system, although there have been reservations as to what degree neuromasts are 
inactivated, what concentration is appropriate for different species, and what influence 
Ca
++ 
concentration in water has on the effectiveness of cobalt chloride (Baker and 
Montgomery, 1999; Janssen, 2000; Montgomery et. al, 1997; Karlsen and Sand, 1975).  
Janssen (2000) discussed the effects of CoCl2 concentration on hair cell inactivation and 
that interspecies differences may occur. He also indicated that using CoCl2 concentrations 
higher than those suggested by Karlsen and Sand (1987; i.e. 0.1 mM for 12-24 hours) 
may be toxic to fish and would affect their overall health and behavior.  Montgomery 
(1997) and Baker and Montgomery (1999) used a 2 mM solution of CoCl2  for 3 hours to 
inactivate the lateral line system in Mexican blind cave fish. Janssen (2000) suggested 
that their behavioral data might have been due to CoCl2 toxicity instead of a true response 
to CoCl2 neuromast ablation. For this reason, and as a result of preliminary experiments, a 
0.1 mM CoCl2 solution was used so that toxicity did not play a role in hair cell 
inactivation.  
The results of the current study support the findings of Karlsen and Sand (1987) that a 
lower concentration of Ca
++
 in the water during treatment with CoCl2 results in stronger 
reduction of fluorescence, and that lower concentrations of Ca
++
 lead to longer recovery 
time of hair cells after treatment. A stronger ablation effect was indicated by lower CN 
and SN fluorescence scores on Day 0 (day of treatment) for fish treated with CoCl2 in 
Ca
++ 
- free water when compared to those treated with CoCl2 in tank water with Ca
++
. The 
only exception to this was for SNs in A. stuartgranti treated in CoCl2 in Ca
++
 - free water 
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and CoCl2 in tank water with Ca
++
, where statistically similar fluorescence scores were 
obtained on Day 0. An explanation for this is not obvious, but it is possible that high 
levels of Ca
++
 in treatments with CoCl2 in tank water with Ca
++
 (>600 mg/L), in the 
current study, would ensure competition of Ca
++
 with CoCl2 for access to hair cell 
mechanosensory channels. This idea was offered by Karlsen and Sand (1975) for whom a 
0.1 mM CoCl2 concentration combined with higher levels of calcium in the water (1 mM) 
resulted in variable reactions by fish to a mechanosensory stimulus, indicating that 
ablation had occurred in some of the fish, but not in others. This variation in behavior 
may explain why SNs in A. stuartgranti on Day 0 were affected by CoCl2 in tank water 
with Ca
++
, but SNs in Tramitichromis sp. were not (i.e. ablation occurred in some of the 
fish [A. stuartgranti ], but not in others [Tramitichromis sp.]). In addition, Schwalbe et al. 
(2012) showed that a Ca
++
 concentration of 60 mg/L (which is 3 times the concentration 
used in the Ca
++
 free treatments in the current study) with 0.1 mM CoCl2 was sufficient to 
reduce or eliminate feeding behavior in A. stuartgranti .  
Recovery after treatment with CoCl2 in Ca
++
 - free water is revealed by an increase in 
SN and CN fluorescence scores over the course of the 7-day recovery period. In 
Tramitichromis sp., both CNs and SNs were recovered by Day 4, as indicated by the 
return of fluorescence. In A. stuartgranti both SNs and CNs recovered from treatment 
with CoCl2 in Ca
++ 
- free water by Day 7, three days later than in Tramitichromis.   
The difference in recovery time (4 days vs. 7 days) may be due to the fact that A. 
stuartgranti has much larger canal neuromasts than does Tramitichromis (see Chapter 1). 
The smaller canal neuromasts in Tramitichromis likely have fewer hair cells, which in 
turn may initially be affected by CoCl2 in Ca
++
free water over the three hour treatment 
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period, but they have fewer hair cells to regenerate or recover from CoCl2 (i.e. Ca
++
 
replaces CoCl2 in hair cells), which would take less time. Since CNs in A. stuartgranti 
likely have more hair cells based on their larger size, they may require a longer time to 
replace CoCl2 with Ca
++
 in mechanosensory channels in the numerous hair cells 
(recovery), or a longer time to regenerate new hair cells (Schwalbe et al., 2012).  
In Tramitichromis, a clear increase in fluorescence scores after ablation with CoCl2 in 
tank water with Ca
++
 was not observed, indicating that hair cells in CNs and SNs were 
not recovering from ablation. In A. stuartgranti this pattern was anomalous such that SNs 
in fish treated with CoCl2 in tank water with Ca
++
 increased in fluorescence score over 
the 7-day recovery period. Since SNs were affected on Day 0, then it makes sense that 
regeneration and/or recovery of hair cells would occur over the 7 days, as with the hair 
cells in CoCl2 in Ca
++ 
- free water treatments.  CNs in A. stuartgranti treated with CoCl2 
in tank water with Ca
++
 did not show this clear pattern of recovery like their SNs, and 
CNs had fluorescence scores similar to Tramitichromis sp., showing no recovery.  
 
Gentamicin Ablation  
Previous studies have used Scanning Electron Microscopy (SEM) to visualize 
neuromasts after treatment with aminoglycoside antibiotics (i.e. neomycin and 
gentamicin). Some of these studies illustrated the disruption of hair cells in CNs, but not 
SNs (Song et al., 1995). However, new evidence presented by Van Trump et al. (2010) 
and the results obtained in the current study, which used fluorescent staining (DASPEI 
and 4-Di-2-ASP, respectively), make it clear that gentamicin does have an effect on both 
CNs and SNs.   
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Gentamicin can inactivate hair cells in two ways: 1) by blocking the 
mechanotransduction channels (Hudspeth and Kroese, 1983; Kroese et al., 1989; Pichler 
et al. 1996), or 2) by causing the degeneration of cilia and subsequent hair cell death 
(Williams et al., 1987; Forge and Schacht, 2000). Both of these mechanisms disrupt hair 
cell function and prevent the uptake of 4-Di-2-ASP. However, SEMs would show only 
hair cell death, and would not reveal the blocking of mechanotransduction channels. Song 
et al. (1995) used SEMs to view CNs and SNs after treatment with gentamicin, but 
reported hair cell death in canal neuromasts only. In contrast, Van Trump et al. (2010) 
and this study show reduction or elimination of fluorescence staining in both canal and 
superficial neuromasts in Mexican blind cave fish, A. stuartgranti , and Tramitichromis 
sp., respectively, indicating that gentamicin may block the mechanotransduction channels 
and cause hair cell death in both CNs and SNs.  
An important contribution of the current study is the analysis of the time course of 
recovery after treatment with CoCl2 or gentamicin. Song et al. (1995) only looked at 
neuromast recovery using SEMs from gentamicin in fish 4 days post-treatment, which is 
the time at which our results indicate full recovery from gentamicin. Hair cells in CNs 
and SNs are constantly being added and regenerated, and newly formed SNs contain 
many more immature hair cells that are resistant to gentamicin (Rubel, 1978). So when 
Song et al. (1995) looked at SEMs at 4 days post treatment, the hair cells in the SNs may 
have already regenerated/recovered, or may have been unaffected due to immaturity 
(Murakami et al., 2003).  
The results obtained in this study indicate that gentamicin has the same effect on 
both SNs and CNs. The recovery time of SNs and CNs is also comparable, suggesting 
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that by 4 days post treatment, neuromast hair cells have either regenerated or recovered 
from gentamicin exposure.  
 
Comparison of Cobalt and Gentamicin Ablation Methods  
CoCl2 and gentamicin have been used in a number of lateral line ablation 
experiments, at a number of different concentrations, and on a number of different 
species (roach, Karlsen and Sand, 1987; oscar, Song et al., 1995; Mexican blind cave 
fish, Montgomery et al., 1997; Mexican blind cave fish, Baker and Montgomery, 1999; 
Mexican blind cave fish, Janssen, 2000; Coombs et al., 2001; zebrafish, Harris et al., 
2003; rainbow trout, Liao, 2006; zebrafish, Owens et al., 2009; Mexican blind cave fish 
and zebrafish, Van Trump et al., 2010; zebrafish, Buck et al. , 2012; A. stuartgranti 
stuartgranti, Schwalbe et al., 2012). It is clear from the current study that a 0.1 mM 
CoCl2 in Ca++ - free water solution (as suggested in Karlsen and Sand, 1987) and a 
0.04% gentamicin solution (based on Van Trump et al., 2010) are the most effective 
ablation techniques to use on cichlids in the genera Tramitichromis sp. and A. 
stuartgranti .  
It is important to note that in fish treated with CoCl2 in Ca
++ 
- free water, 
fluorescence scores for CNs on Day 0 were lower in Tramitichromis sp. than in A. 
stuartgranti , indicating that a larger proportion of hair cells had been ablated in 
Tramitichromis sp. In addition, neuromast recovery time was about 3 days longer in A. 
stuartgranti than Tramitichromis sp. It is possible that on Day 0, A. stuartgranti CNs, 
which are larger and presumably contain more hair cells than those in Tramitichromis sp., 
had fewer hair cells that were affected because there was not a long enough exposure 
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time to ablate all of them. It follows that Tramitichromis sp. has smaller neuromasts and 
presumably fewer hair cells, all or most of which were ablated, as indicated by a much 
reduced fluorescence score. The fact that A. stuartgranti fluorescence scores took 3 days 
longer to increase to the same fluorescence score as control fish, thus indicating recovery, 
when compared to Tramitichromis sp., may be due to the regeneration or repair of a 
larger proportion of hair cells in canal neuromasts.  
On the other hand, gentamicin treatment had the same effects on fluorescence 
scores for SNs and CNs in both species on Day 0 and on subsequent recovery days. This 
might indicate that treatment with 0.04% gentamicin for 24 hours is a more appropriate 
ablation method to use on fish with widened canals to ensure complete ablation of their 
larger canal neuromasts in addition to their SNs. Gentamicin-treated fish did have CN 
and SN fluorescence scores that were similar to CoCl2 in Ca
++
 - free water, so both 
methods likely have the same overall effect on behavior.  
All previously published lateral line ablation experiments have been conducted on 
species with narrow canals (like Tramitichromis), which have relatively small canal 
neuromasts, or on species with a proliferation of superficial neuromasts (i.e. Mexican 
blind cave fish), which are also small in size and relatively low in hair cell number. An 
exception to this is the work of Schwalbe et al. (2012; A. stuartgranti stuartgranti).  
Finally, the styryl dye 4-Di-2-ASP provided a rapid and largely reliable method 
for visually assessing the effects of both cobalt and gentamicin on neuromast hair cells in 
two species of cichlids with different lateral line canal morphologies. The results 
presented here show that verification of neuromast ablation using fluorescent staining is 
important for verifying behavioral experiments. 
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Table 2.1. The effect of cobalt chloride and gentamicin and on mandibular canal 
neuromasts in Tramitichromis sp. as revealed by 4-Di-2-ASP staining. Mean +SE scores 
for staining of the 10 mandibular canal neuromasts (5 right, 5 left) in three treatments with 
controls on day of treatment (Day 0 and then Days 2, 4, 7). Score 0=no 4-Di-2-ASP 
staining, Score 1=partial staining, and Score 2=full normal staining. See Fig. 7 for 
examples of canal neuromasts scored as 0, 1, and 2. 
 
 
 
 
Treatment  Day 0  Day 2  Day 4  Day 7 
CoCl2 0.1mM in 
Ca
++ 
-free tank water 
  
0 
  
1 
  
2 
  
1.5 
 0.4  1  2  2 
 0.4  0.5  2  2 
 0.3 
 
±0.13  0.8  ±0.17  2.0 ±0.00  1.8 ±0.17 
Ca
++ 
-free tank water 
(Control) 
 2  2  2  1.9 
 2  1.8  2  1.8 
 2  1.7  2  2 
 2.0 ±0.00  1.8 ±0.09  2.0 ± 0.00  1.9 ±0.06 
CoCl2 0.1mM% in 
tank water with 
calcium   
 1.8  2  1.9  1.4 
 1.7  1.4  1.7  1.8 
 2  1  1.8  1.8 
 1.8 ± 0.09  1.5 ±0.29  1.8 ±0.06  1.7 ±0.13 
Tank water with 
calcium (Control) 
 1.9  1.9  2  2 
 1.9  1.6  1.9  2 
 2  1.5  2  2 
 1.9 ±0.03  1.7 ± 0.12  2.0 ±0.00  2.0 ±0.00 
Gentamicin 0.04% in 
tank water 
 0  1  2  2 
 0.5  1  2  2 
 0.3  1  2  2 
 0.3 ± 0.15  1.0 ± 0.00  2.0 ±0.00  2.0 ± 0.00 
Tank water  
(Control) 
 2  2  2  2 
 2  2  2  2 
 -  2  2  2 
 2.0 ±0.00  2.0 ±0.00  2.0 ±0.00  2.0 ±0.00 
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Table 2.2. The effect of gentamicin and cobalt chloride on mandibular canal neuromasts in 
A. stuartgranti. Mean + SE scores for staining of the 10 mandibular canal neuromasts (5 
right, 5 left) in three treatments with controls on day of treatment (Day 0 and then Days 2, 
4, 7). Score 0=no 4-Di-2-ASP staining, Score 1=partial staining, and Score 2=full normal 
staining. See Fig. 7 for examples of canal neuromasts scored as 0, 1, and 2. 
 
 
Treatment  Day 0  Day 2  Day 4  Day 7 
CoCl2 0.1mM in 
Ca
++ 
-free tank 
water 
  
0.7 
  
0.2 
  
1.1 
  
2 
 0.4  0.9  1.5  1.8 
 0.9  0.9  1.4  1.9 
 0.7 + 0.15  0.7 + 0.23  1.3 + 0.12  1.9 + 0.06 
Ca
++ 
-free tank 
water (Control) 
 2  2  2  2 
 2  1.9  2  2 
 2  2  2  1.7 
 2.0 +0.00  2.0 + 0.03  2.0 +0.00  1.9+ 0.10 
CoCl2 0.1mM% in 
tank water with 
calcium   
 1.8  1  1.9  2 
 1.8  1.8  1  2 
 1.4  1.4  2  2 
 1.7 + 0.13  1.4 +0.23  1.6 + 0.32  2 +0.00 
Tank water with 
calcium (Control) 
 1.8  2  2  2 
 1.8  2  2  2 
 2  -  -  - 
 1.9 + 0.07  2.0±0.00  2.0±0.00  2.0±0.00 
Gentamicin 0.04% 
in tank water 
 0.2  1  2  1.9 
 0.2  1.8  2  1.9 
 0.2  1.3  2  2 
 0.2 +0.00  1.4 +0.23  2.0 + 0.00  1.9 + 0.03 
Tank water  
(Control) 
 2  1.9  2  2 
 2  1.9  2  1.8 
 2  2  -  2 
 2.0 + 0.00  1.9 + 0.03  2.0 ±0.00  1.9 + 0.07 
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Table 2.3. The effect of gentamicin and cobalt chloride on mandibular superficial 
neuromasts in Tramitichromis sp. Mean score of mandibular SNs scored as 1 or 2, three 
treatments with controls over 7 days. 1=partial staining and a score of 2=full normal 
staining. See Fig. 7 for examples of SNs scored as 1 and 2. 
 
 
 
 
 
 
Treatment  Day 0  Day 2  Day 4  Day 7 
CoCl2 0.1mM in 
Ca
++ 
-free tank water 
  
1.0 
 
1.0 
 
1.9 
 
1.8 
 1.3  1.0  1.7  1.7 
 1.0  1.0  1.6  1.6 
 1.06 ±0.04  1.00 ±0.00  1.7 ±0.06  1.73 ±0.08 
Ca
++
 -free tank water 
(Control) 
 1.8  1.8  1.8  2.0 
 1.7  1.7  1.9  1.9 
 2.0  1.5  1.9  2.0 
 1.76 ±0.08  1.73 ±0.08  1.83±0.069  1.97 ±0.03 
CoCl2 0.1mM in tank 
water with Ca
++
 
 2.0  2.0  1.2  1.9 
 1.8  1.8  1.0  2.0 
 1.8  1.9  1.3  1.5 
 1.9 ±0.06  1.9 ±0.07  1.07 ±0.05  1.93 ±0.05 
Tank water with 
calcium( Control) 
 2.0  1.9  1.6  2.0 
 2.0  2.0  1.8  2.0 
 
1.6 
 
1.9 
 
1.5 
 
2.0 
 1.87 ± 0.06  1.93 ±0.05  1.67 ± 0.09  2.0 ± 0.00 
Gentamicin 0.04% 
in tank water 
 1.0  1.0  2.0  2.0 
 1.0  1.6  1.7  1.9 
 1.0  1.9  1.9  2.0 
 1.00 ± 0.00  1.17 ±0.07  1.87 ±0.03  1.97 ±0.03 
Tank water only 
(Control) 
 2.0  1.9  1.9  1.8 
 2.0  2.0  1.6  1.9 
 -  2.0  1.9  2.0 
 2.0 ± 0.00  1.97 ±0.06  1.8 ±0.07  1.87 ±0.07 
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Table 2.4. The effect of gentamicin and cobalt chloride on mandibular superficial 
neuromasts in A. stuartgranti. Mean score of mandibular SNs scored as 1 or 2, for three 
treatments with controls over 7 days. 1=partial staining and a score of 2=full normal 
staining. See Fig. 7 for examples of SNs scored as 1 and 2. 
 
 
 
 
 
 
 
 
Treatment  Day 0  Day 2  Day 4  Day 7 
CoCl2 0.1mM in 
Ca
++
-
 
free tank 
water 
  
1.0 
 
1.0 
 
1.6 
 
1.9 
 1.0  1.0  1.5  1.7 
 1.0  1.0  1.7  1.6 
 1.00 ±0.00  1.00 ±0.00  1.53 ±0.09  1.83 ±0.07 
Ca
++
 -free tank 
water 
(Control) 
 2.0  2.0  2.0  2.0 
 2.0  1.9  2.0  1.9 
 2.0  2.0  2.0  2.0 
 2.00 ±0.00  1.96 ±0.033  2.00 ±0.00  1.96 ±0.033 
CoCl2 0.1mM in 
tank water with 
Ca
++
 
 1.0  1.3  1.7  2.0 
 1.0  1.0  1.4  2.0 
 1.1  1.0  1.6  1.5 
 1.03 ±0.03  1.20 ±0.07  1.46 ±0.09  1.76 ±0.08 
Tank water with 
calcium( 
Control) 
 2.0  2.0  2.0  2.0 
 2.0  2.0  2.0  2.0 
 
2.0 
 
- 
 
- 
 
- 
 2.0 ± 0.00  2.0 ± 0.00  2.0 ± 0.00  2.0 ± 0.00 
Gentamicin 
0.04% 
in tank water 
 1.0  1.5  1.9  1.8 
 1.0  1.1  1.9  1.8 
 1.0  1.5  1.7  2.0 
 1.0 ± 0.00  1.40 ±0.09  1.86 ±0.06  1.73 ±0.08 
Tank water only 
(Control) 
 1.3  2.0  1.9  1.7 
 1.6  2.0  1.9  1.8 
 1.8  1.9  -  2.0 
 1.46 ± 0.09  1.96 ±0.03  1.90 ±0.05  1.83 ±0.07 
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Table 2. 5. Summary statistics for CoCl2 and gentamicin treated Tramitichromis sp. canal neuromast 
comparisons. * indicates a p-value <0.05.  
 
  Significance   p- value 
Day 0     
0.1mM CoCl2in Ca
++
free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.9633 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  ns  > 0.9999 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.8199 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  0.9774 
63M Gentamicin vs. Tank water (Gentamicin control)  *  < 0.0001 
Day 2     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.3112 
Ca
++ 
- free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.3112 
Ca
++ 
- free water (Control) vs. Tank water (Gentamicin control)  ns  0.3112 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.1349 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  *  0.0006 
63M Gentamicin vs. Tank water (Gentamicin control)  *  < 0.0001 
Day 4     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  ns  > 0.9999 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  ns  0.1349 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.9985 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  ns  > 0.9999 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.3112 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.1349 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  0.9985 
63M Gentamicin vs. Tank water (Gentamicin control)  ns  > 0.9999 
Day 7     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++ 
- free water (Control)  ns  0.9633 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  ns  0.3112 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.3112 
Ca
++ 
- free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.8199 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  ns  0.8199 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  0.0006 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  0.0006 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  > 0.9999 
63M Gentamicin vs. Tank water (Gentamicin control)  ns  > 0.9999 
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Table 2. 6. Summary statistics for CoCl2 and gentamicin treated Tramitichromis sp. superficial 
neuromast comparisons.  * indicates a p-value < 0.05.  
 
       
  Significance  p- value 
Day 0     
0.1mM CoCl2in Ca
++
free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.9624 
Ca
++ 
- free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.5620 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  *  0.0125 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.9984 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  0.5620 
63M Gentamicin vs. Tank water ( Gentamicin control)  *  < 0.0001 
Day 2     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.3048 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.1305 
Ca
++ 
- free water (Control) vs. Tank water ( Gentamicin control)  ns  0.5620 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.9984 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  0.9624 
63M Gentamicin vs. Tank water ( Gentamicin control)  *  < 0.0001 
Day 4     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  ns  0.9984 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.8162 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.3048 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  ns  0.9984 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  < 0.0001 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  0.5620 
63M Gentamicin vs. Tank water ( Gentamicin control)  ns  0.3048 
Day 7     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++ 
- free water (Control)  *  0.0448 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  ns  0.1305 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  *  0.0448 
Ca
++ 
- free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.9984 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  ns  0.5620 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.9624 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.9984 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  0.3048 
63M Gentamicin vs. Tank water ( Gentamicin control)  ns  0.5620 
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Table 2. 7. Summary statistics for CoCl2 and gentamicin treated A. stuartgranti canal neuromast 
comparisons. * indicates a p-value < 0.05.  
 
  Significance  p-value 
Day 0     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  *  < 0.0001 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.6601 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  ns  > 0.9999 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  0.2122 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  0.6601 
63M Gentamicin vs. Tank water (Gentamicin control)  *  < 0.0001 
Day 2     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  *  < 0.0001 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  ns  0.9750 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  < 0.0001 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.9990 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  0.9848 
63M Gentamicin vs. Tank water ( Gentamicin control)  *  < 0.0001 
Day 4     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  *  0.0096 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  *  < 0.0001 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  ns  > 0.9999 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  0.0031 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  0.0006 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  > 0.9999 
63M Gentamicin vs. Tank water ( Gentamicin control)  ns  > 0.9999 
Day 7     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  ns  > 0.9999 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ Ca
++
)  ns  0.8689 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.9990 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.9144 
Ca
++
 - free water (Control) vs. Tank water ( Gentamicin control)  ns  0.9990 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  ns  > 0.9999 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.9750 
Tank water (w/ Ca
++
, control) vs. Tank water ( Gentamicin control)  ns  0.9848 
63M Gentamicin vs. Tank water ( Gentamicin control)  ns  > 0.9999 
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Table 2. 8. Summary statistics for CoCl2 and gentamicin treated A. stuartgranti superficial 
neuromast comparisons. * indicates a p-value < 0.05.  
  Significanc
e 
 p- value 
Day 0     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++ 
- free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ 
Ca
++
) 
 
ns 
 
0.9988 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  *  < 0.0001 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  < 0.0001 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.9983 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  *  < 0.0001 
63M Gentamicin vs. Tank water (Gentamicin control)  
* 
 
< 0.0001 
Day 2     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ 
Ca
++
) 
 
ns 
 
0.1137 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  *  < 0.0001 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.9983 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  ns  > 0.9999 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  < 0.0001 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.1137 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  0.9983 
63M Gentamicin vs. Tank water (Gentamicin control)  
* 
 
< 0.0001 
Day 4     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  *  < 0.0001 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ 
Ca
++
) 
 
ns 
 
0.9585 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  *  0.0004 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  > 0.9999 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  ns  0.8009 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  < 0.0001 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  *  < 0.0001 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  0.8009 
63M Gentamicin vs. Tank water (Gentamicin control)  
ns 
 
0.9983 
Day 7     
0.1mM CoCl2in Ca
++
-free water vs. Ca
++
 - free water (Control)  ns  0.5360 
0.1mM CoCl2in Ca
++
-free water vs. 0.1 mM CoCl2in tank water (w/ 
Ca
++
) 
 
ns 
 
0.9585 
0.1mM CoCl2in Ca
++
-free water vs. 63M Gentamicin  ns  0.8009 
Ca
++
 - free water (Control) vs. Tank water (w/ Ca
++
, control)  ns  0.9983 
Ca
++
 - free water (Control) vs. Tank water (Gentamicin control)  ns  0.5360 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. Tank water (w/ Ca
++
, control)  *  0.0368 
0.1 mM CoCl2in tank water (w/ Ca
++
) vs. 63M Gentamicin  ns  0.9983 
Tank water (w/ Ca
++
, control) vs. Tank water (Gentamicin control)  ns  0.2791 
63M Gentamicin vs. Tank water (Gentamicin control)  ns  0.8009 
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Fig. 2.1. 4-Di-2-ASP dose response in A. stuartgranti. A) 15.8 μM solution, B) 31.5 
μM solution , C) 47.3 μM solution , and D) 63 μM solution. All images captured at the 
same exposure. Scale bar is ~ 1 mm.  
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Fig. 2.2 . Ventral view of fluorescent stain comparison in mandibular canal and 
superficial neuromasts in A. stuartgranti . A) 3µM  FM1-43 for 5 minutes, B) 
0.01% DASPEI for 30 minutes, and C) 63µM 4-Di-2-ASP for 5 minutes. All 
pictures taken at the same exposure.  Scale bar is ~ 1 mm. 
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Fig.2.3. Cobalt chloride treatment flow chart for Tramitichromis sp. and A. stuartgranti. 
On Day 0, 3 fish from each treatment or control were stained with 4-Di-2-ASP, while the 
remaining 9 fish were placed in recovery tanks with tank water (w/calcium). On Days 2, 
4, and 7, 3 fish were removed from the recovery tank and treated with 4-Di-2-ASP in the 
same way as on Day 0.  
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Fig. 2.4. A. stuartgranti gentamicin dose response.  A) 0.01% gentamicin solution 
for 24 hours, B) 0.02 % gentamicin solution for 24 hours, C) 0.03% gentamicin  
for 24 hours, and D) 0.04% gentamicin solution for 24 hours. Note the 
diminishing fluorescence in canal and superficial neuromasts with an increase in 
concentration. All images taken with the same exposure time. Scale bar is ~ 1 
mm.  
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Fig. 2.5. A. stuartgranti 24-hour gentamicin exposure test. 0.5- 24 hours post 
treatment (PT) with 0.04% gentamicin solution. Note the diminishing 
fluorescence in canal and superficial neuromasts by 10.5 hr PT. The same 
exposure time was used for all images. Scale bar is ~ 1 mm.  
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 Fig.6 
 
 
 
 
 
 
 
 
Fig. 2.6. Gentamicin treatment flow chart for Tramitichromis sp. and A. stuartgranti . On 
Day 0, 3 fish from each treatment were treated with 4-Di-2-ASP, while the remaining 9 
fish were placed in recovery tanks with tank water (w/ calcium). On Days 2, 4, and 7, 3 
fish were pulled from the recovery tank and treated with 4-Di-2-ASP in the same way as 
Day 0. 
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Fig. 2.7. Canal and superficial neuromast scoring in Tramitichromis sp. and A. 
stuartgranti . A-C) Tramitichromis sp. Canal Neuromasts, D-F) A. stuartgranti 
Canal Neuromasts, G-H) Tramitichromis sp. Superficial Neuromasts, I-J) A. 
stuartgranti Superficial Neuromasts. “0” indicates a neuromast scored as 0, “1” 
indicates a neuromast scored as 1, and “2” indicates a neuromast scored as 2. Note 
that superficial neuromasts could not be scored as 0, so those images are absent. 
Scale bars in C and H are ~30μm. Scale bars in F and J are ~60μm.  
 
 
Tramitichromis sp.  A. stuartgranti  
 
Superficial Neuromasts 
Tramitichromis sp.   A. stuartgranti  
Canal Neuromasts 
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Fig. 2.8. Day 0 (day of treatment) mean canal neuromast fluorescent score in all 
treatments in A) Tramitichromis sp.and B) A. stuartgranti. Asterisk (*) denotes a 
significant difference between the treatment and control mean score. See Tables 5 and 
7 for statistics.
* * 
* * ns 
ns 
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Fig. 2.9. Mean canal neuromast fluorescence score (0-2) over 7 days in all treatments. A-
C) Tramitichromis sp. , D-F) A. stuartgranti ; A and D) Cobalt Chloride in Ca
++
- free 
water, B and E)  Cobalt Chloride in tank water (w/ calcium), C and F) Gentamicin in tank 
water. Asterisk (*) indicates a significant difference between the treatment and control on 
that day. 
* 
* 
* 
* * 
* * * 
* * 
* * 
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Fig. 2.10. Mean superficial neuromast fluorescence score (1-2) over 7 days in all 
treatments. A-C) Tramitichromis sp., D-F) A. stuartgranti ; A and D) Cobalt Chloride in 
Ca
++
 -free water, B and E)  Cobalt Chloride in tank water (w/ calcium), C and F) 
Gentamicin in tank water. 
* * 
* 
* 
* * 
* * * 
* * * * 
* 
* 
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Fig. 2.11. Recovery from cobalt chloride in Tramitichromis sp. over 7 days as illustrated with 4-Di-2-ASP.  A-D) 0.1 mM Cobalt 
Chloride in Ca
++
-free water treatment for 3 hours , E-H) Ca
++
-free water (control) treatment for 3 hours, I-L) 0.1 mM Cobalt Chloride 
in tank water (w/ calcium) for 3 hours, and M-P) Tank water (w/ calcium; control) for 3 hours. 
7
5
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Fig. 2.12. Recovery from cobalt chloride in A. stuartgranti over 7 days as illustrated by 4-Di-2-ASP.  A-D) 0.1 mM Cobalt Chloride in 
Ca
++
 -free water treatment for 3 hours , E-H) Ca
++
 -free water (control) treatment for 3 hours, I-L) 0.1 mM Cobalt Chloride in tank 
water (w/ calcium) for 3 hours, and M-P) Tank water (w/ calcium; control) for 3 hours.
7
6
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Fig.2.13. Recovery of Tramitichromis sp. from gentamicin over 7 days. A-D) 63 µM 
Gentamicin in tank water for 24 hours, E-H) Tank water (control) for 24 hours.  
 
 78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.14. Recovery of A. stuartgranti from gentamicin over 7 days.  A-D) 63 
µM Gentamicin in tank water for 24 hours, E-H) Tank water (control) for 24 
hours. 
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Fig. 2.15. Patterns of hair cell labeling in canal neuromasts treated with CoCl2 
and gentamicin in Tramitichromis sp. and A. stuartgranti . A) hair cell labeling is 
absent from the center of the neuromast, B) hair cell labeling is absent from the 
outer ring of the neuromast, C) hair cell labeling is absent around outside and 
center of neuromast, and D) hair cell labeling is completely absent in the 
neuromast. All images are representative samples from A. stuartgranti and 
Tramitichromis in all three treatments.  SNs were too small to detect similar 
patterns.  
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